Clinical trials are essential for developing new treatments and therapies. However, the stringent regulations governing these trials can be a significant barrier. Ethical considerations, patient recruitment, and compliance with Good Clinical Practice (GCP) guidelines are some hurdles that researchers face. These regulations are crucial for ensuring patient safety but can also delay the introduction of innovative treatments.
